Recent Trends in Kinase Drug Discovery
Overview of KINOMEscan binding assay technology platform, including applications to polypharmacology and covalent inhibition and the expansion of the KINOMEscan binding assay technology platform to new services: E3scan with applications in targeted protein degradation of kinases and SH2scan with applications in allosteric targeting of kinases